Rezaee Zahra, Ghaseminejad Azizeh, Forootan Mitra, Hosseinipoor Taraneh, Forghani Forough
Obstetrics and Gynecology Department, Tehran University of Medical Sciences, Tehran, Iran.
Zabol University of Medical Sciences, Zabol, Iran.
Int J Fertil Steril. 2012 Jan;5(4):231-4. Epub 2012 Mar 20.
Polycystic ovarian syndrome (PCOS) is one of the most common causes of endocrine disorders and main reasons for infertility due to unovulation and recurrent abortions. There is no consensus on effect of serum progesterone level on the day of human chorionic gonadotropin (hCG) injection. This study aims to evaluate the effect of plasma levels of progesterone on the day of hCG injection on the rate of pregnancy in in vitro fertilization (IVF) cycles of PCOS cases.
A stratified cohort study was conducted over a period of one year (2009) on 38 infertile women with PCOS who were suitable candidates for the IVF program. Patients were evaluated for other causes of infertility with hysterosalpingography (HSG), laparoscopy and normal sperm analysis. Patients were placed on the long protocol, followed by oocyte pick up, and finally IVF-embryo transfer (ET). Study patients were grouped according to progesterone levels of greater or less than 1.2 ng/ml on the day of hCG injection. Pregnancy rates were defined in each group. Levels on day of hCG day clinical pregnancy outcome were assessed. Experimental data were then compared against Fisher's exact test in SPSS version 18.
The overall pregnancy rate in this study was 26.3%. In the group with progesterone levels more than 1.2 ng/ml on the day of hCG injection, the clinical pregnancy rate was 4 (21.1%) and chemical pregnancy rate was 3(15.8%). In the group with progesterone levels less than 1.2 ng/ml, the clinical pregnancy rate was 1(5.3%) and chemical pregnancy rate was 2(10. 5%).
This study showed that PCOS patients with progesterone levels more than 1.2 ng/ml on the day of hCG injection resulted in higher chemical and clinical pregnancy rates. However, no significant statistical differences were found between the two groups. For further verification, we recommend additional studies with larger numbers of subjects.
多囊卵巢综合征(PCOS)是内分泌紊乱的最常见原因之一,也是无排卵和反复流产导致不孕的主要原因。关于人绒毛膜促性腺激素(hCG)注射日血清孕酮水平的影响尚无共识。本研究旨在评估PCOS患者体外受精(IVF)周期中hCG注射日血浆孕酮水平对妊娠率的影响。
2009年进行了一项为期一年的分层队列研究,研究对象为38例适合IVF计划的PCOS不孕女性。通过子宫输卵管造影(HSG)、腹腔镜检查和正常精子分析评估患者不孕的其他原因。患者采用长方案,随后进行取卵,最后进行IVF胚胎移植(ET)。根据hCG注射日孕酮水平大于或小于1.2 ng/ml对研究患者进行分组。定义每组的妊娠率。评估hCG日临床妊娠结局当天的水平。然后在SPSS 18版中使用Fisher精确检验对实验数据进行比较。
本研究的总体妊娠率为26.3%。在hCG注射日孕酮水平高于1.2 ng/ml的组中,临床妊娠率为4例(21.1%),化学妊娠率为3例(15.8%)。在孕酮水平低于1.2 ng/ml的组中,临床妊娠率为1例(5.3%),化学妊娠率为2例(10.5%)。
本研究表明,hCG注射日孕酮水平高于1.2 ng/ml的PCOS患者化学妊娠率和临床妊娠率更高。然而,两组之间未发现显著的统计学差异。为进一步验证,我们建议进行更多受试者的额外研究。